Therefore, future analysis ought to be focused on analyzing changes in the morphology of the Ishikawa endometrial cancer cell line under cisplatin and leptin treatment by using more precise methods, such as the DAPI assay. The gene discussed is LEP; the disease is endometrial cancer.